AzTrials
AzTrials

IrisinEx-IrisinNCT07146490

Effects of Different Types of Exercise on Irisin and Cognitive Performance (Exercise-Irisin)

A study testing Low Exercise, Long Interval Exercise and Short Intevral Exercise in people with Irisin and Lactate, run by Aksaray University Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose The purpose of this study was to determine the acute effects of different exercise intensities on Irisin levels, trail making test performance, and feeling scale. Method This randomized crossover controlled trial aims to examine the acute effects of three experimental conditions-Short-Interval High-Intensity… Read more about this study

Who is it for?
Ages 18 to 25 years, men onlyHealthy volunteers can take part
Conditions the study is for
Irisin, Lactate, Cognitive Function
What is being tested?
Low Exercise, Long Interval Exercise and Short Intevral Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Jun 2025to 5 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 25 years
  • No known medical condition that prevents participation in exercise
  • Not currently using any pharmacological agents

Who cannot join

  • Experiencing any discomfort before, during, or after exercise
  • Current or past diagnosis of pharmacological or doping substance use
  • Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
  • History of alcohol or substance addiction
  • Any other condition or factor that may prevent full participation in the study protocol

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Aksaray University

    Aksaray, Center, 68000

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Exercise Intensity on Neurochemical and Cognitive Function: The Role of Lactate and Irisin

Purpose The purpose of this study was to determine the acute effects of different exercise intensities on Irisin levels, trail making test performance, and feeling scale.

Method

Read more

This randomized crossover controlled trial aims to examine the acute effects of three experimental conditions-Short-Interval High-Intensity Interval Training (SI-HIIT), Long-Interval High-Intensity Interval Training (LI-HIIT) and Low-Intensity Continuous Training (LICT), on cognitive performance (via the Trial Making Test, ) and associated neurochemical responses (e.g., serum Irisin and blood lactate levels) in healthy young adults aged 18-25 years.

All participants completed the three conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of three groups (n = 4 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-3) and that the order minimized sequence effects by rotating the position of each condition relative to the others.

To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (Irisin increases reported -no two high-intensity sessions were scheduled consecutively. Where possible, higher and lower intensity protocols were be alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.

The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis.

All exercise sessions conducted under supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol in the morning (09:00-11:00) on a track and field pitch to control for chronobiological variation. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were to remain unchanged throughout the study.

During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed, aerobic capacity, and peak heart rate.

In the following four visits, each participant completed all experimental conditions. Each exercise session began with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.

All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's maximal aerobic speed, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's maximal aerobic speed, ensuring workload equivalence across conditions.

  • Short-interval high-Intensity Interval Training: Participants ran at 110-120% of their MAS for 15-second intervals.
  • Long-interval high-Intensity Interval Training: Participants ran at a speed corresponding to 80-90% of their MAS.
  • Low-Intensity Continuous Training: Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.

Venous blood samples were collected before and immediately after each session to assess neurochemical markers. Subsequently, cognitive performance was evaluated using the computerized Trial Making Test to measure executive function. Heart rate was continuously monitored during all exercise conditions using a Polar V800 device. Following each session, psychophysiological responses were assessed using the Feeling Scale.

Being tested
Low Exercise, Long Interval Exercise, Short Intevral Exercise
Keywords
HIIT, Irisin, Lactate, Cognitive Function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low ExerciseBehavioural

    Low-Intensity Continuous Training (LICT): Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.

  • Long Interval ExerciseBehavioural

    Long-interval high-Intensity Interval Training (LI-HIIT): Participants ran at a speed corresponding to 80-90% of their MAS. The protocol consisted of four 4-minute bouts, separated by 2-minute active recovery periods, during which participants ran at 50% of their MAS. This pattern totaled 24 minutes of exercise.

  • Short Intevral ExerciseBehavioural

    Short-interval high-Intensity Interval Training (SI-HIIT): Participants ran at 110-120% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they rested passively for 15 seconds and returned to their starting point. This was repeated continuously for 3 minutes, constituting one set. A total of four 3-minute sets were completed, interspersed with 3-minute passive rest periods, yielding a total exercise time of 24 minutes.

Study groups in NCT07146490
Study groupRoleWhat they receive
Low-Intensity Continuous Training Group (n=4)ExperimentalThey were asked to perform low intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity.
Receives: Behavioral: Low Exercise
Long-interval high-Intensity Interval Training Group (n=4)ExperimentalThey were asked to perform long interval moderate intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity.
Receives: Behavioral: Long Interval Exercise
Short-interval high-Intensity Interval Training Group (n=4)ExperimentalThey were asked to perform short interval high intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity.
Receives: Behavioral: Short Intevral Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lactate

    Lactate levels were measured in millimoles per liter (mmol/L) from capillary/venous blood samples taken before and after exercise using a lactate analyzer.

    Measured: Baseline and immediately after exercise (Day 1)

  2. Irisin

    Irisin levels were measured using a Sunred brand ELISA kit from blood samples taken baseline and after exercise, and the results were reported in pg/mL units.

    Measured: Baseline and immediately after exercise (Day 1)

  3. Trial Making Test

    The Trail Making Test (TMT) is a widely used neuropsychological assessment tool to evaluate attention, visual scanning, processing speed, mental flexibility, and executive function.

    TMT-A measures processing speed and visual attention by requiring participants to connect sequential numbers (1-25) as quickly as possible. Completion times were recorded in seconds.

    TMT-B measures cognitive flexibility and executive control by requiring participants to alternate between numbers and letters (1-A-2-B, etc.).

    Measured: Baseline and immediately after exercise (Day 1)

  4. Feeling Scale

    The Feeling Scale (FS) is a single-item measure of affective valence during or after exercise. Participants are asked, "How are you feeling right now?" and respond on an 11-point bipolar scale ranging from -5 to +5.

    Scoring:

    -5 = Very Bad

    0 = Neutral

    +5 = Very Good

    Negative scores indicate unpleasant affect, whereas positive scores indicate pleasant affect. Higher scores reflect better subjective feelings.

    Measured: Baseline and immediately after exercise (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2025
  2. Study start10 Jun 2025
  3. Primary completion27 Jul 2025
  4. Study completion5 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07146490
Sponsor's protocol ID
10.03
Acronym
Ex-Irisin
Status last verified
Aug 2025
First submitted
20 Aug 2025
Last updated
4 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Low Exercise, Long Interval Exercise and Short Intevral Exercise in people with Irisin and Lactate, run by Aksaray University Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lactate (time frame: Baseline and immediately after exercise (Day 1)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in